T. Rowe Price Associates’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Sell |
42,935
-31,743
| -43% | -$160K | ﹤0.01% | 2676 |
|
|
2025
Q1 | $484K | Buy |
74,678
+3,346
| +5% | +$21.7K | ﹤0.01% | 2257 |
|
|
2024
Q4 | $524K | Buy |
71,332
+3,506
| +5% | +$25.8K | ﹤0.01% | 2252 |
|
|
2024
Q3 | $509K | Buy |
67,826
+9,983
| +17% | +$74.9K | ﹤0.01% | 2234 |
|
|
2024
Q2 | $515K | Buy |
57,843
+4,464
| +8% | +$39.7K | ﹤0.01% | 2178 |
|
|
2024
Q1 | $541K | Sell |
53,379
-33,225
| -38% | -$337K | ﹤0.01% | 2177 |
|
|
2023
Q4 | $872K | Sell |
86,604
-149,323
| -63% | -$1.5M | ﹤0.01% | 1931 |
|
|
2023
Q3 | $2.21M | Sell |
235,927
-566,107
| -71% | -$5.31M | ﹤0.01% | 1417 |
|
|
2023
Q2 | $19.7M | Buy |
802,034
+415,089
| +107% | +$10.2M | ﹤0.01% | 938 |
|
|
2023
Q1 | $9.01M | Buy |
386,945
+1,297
| +0.3% | +$30.2K | ﹤0.01% | 1076 |
|
|
2022
Q4 | $9.76M | Buy |
385,648
+39
| +0% | +$987 | ﹤0.01% | 1056 |
|
|
2022
Q3 | $7.44M | Buy |
385,609
+209,070
| +118% | +$4.03M | ﹤0.01% | 1119 |
|
|
2022
Q2 | $4.5M | Sell |
176,539
-273,824
| -61% | -$6.97M | ﹤0.01% | 1432 |
|
|
2022
Q1 | $11.6M | Sell |
450,363
-147,070
| -25% | -$3.78M | ﹤0.01% | 1344 |
|
|
2021
Q4 | $25M | Buy |
597,433
+560,914
| +1,536% | +$23.5M | ﹤0.01% | 1229 |
|
|
2021
Q3 | $1.59M | Sell |
36,519
-39,334
| -52% | -$1.71M | ﹤0.01% | 1830 |
|
|
2021
Q2 | $3.59M | Buy |
75,853
+13,874
| +22% | +$656K | ﹤0.01% | 1575 |
|
|
2021
Q1 | $3.18M | Sell |
61,979
-3,437
| -5% | -$176K | ﹤0.01% | 1564 |
|
|
2020
Q4 | $1.75M | Buy |
65,416
+38,960
| +147% | +$1.04M | ﹤0.01% | 1687 |
|
|
2020
Q3 | $908K | Buy |
+26,456
| New | +$908K | ﹤0.01% | 1837 |
|